Abbott’s John McCoy sells 27 shares at $109.54

Abbott Laboratories’ vice president and controller reported small stock sales and tax-related share withholdings, plus a modest indirect holding in a company retirement trust.

Rhea-AI Filing Summary

ABBOTT LABORATORIES (ABT) officer John A. McCoy Jr., Vice President and Controller, reported share dispositions in early September 2026.

On September 2, 2026 he sold 27 common shares at $109.54 per share in a sale described as an open market or private transaction. On September 1, 2026, 52 common shares were delivered or withheld for payment of exercise price or tax liability at $110.36 per share. A separate entry shows 59 common shares held indirectly in the Abbott Laboratories Stock Retirement Trust, described as a Profit Sharing Trust, as of September 1, 2026. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

Net Seller: 27 shares

Net Sell 3 txns

Insider MCCOY JOHN A. JR.

Role VICE PRESIDENT AND CONTROLLER

Sold 27 shs ($3K)

Type	Security	Shares	Price	Value
Sale	Common shares without par value	27	$109.54	$3K
Exercise Price or Tax Liability	Common shares without par value	52	$110.36	$6K
holding	Common shares without par value F1	--	--	--

Holdings After Transaction: Common shares without par value — 24,549 shares (Direct); Common shares without par value — 59 shares (Indirect, Profit Sharing Trust)

Footnotes (1)

1. F1. Balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2026.

Key Figures

Common shares sold: 27 shares Sale price per share: $109.54 per share Shares delivered or withheld: 52 shares +2 more

5 metrics

Common shares sold 27 shares Sale of common shares on September 2, 2026

Sale price per share $109.54 per share Price for 27-share sale on September 2, 2026

Shares delivered or withheld 52 shares Payment of exercise price or tax liability on September 1, 2026

Tax/exercise payment price per share $110.36 per share Price for 52-share disposition on September 1, 2026

Indirect shares in Stock Retirement Trust 59 shares Balance in Abbott Laboratories Stock Retirement Trust as of September 1, 2026

Key Terms

Profit Sharing Trust, Abbott Laboratories Stock Retirement Trust, Payment of exercise price or tax liability, Rule 10b5-1

4 terms

Profit Sharing Trust financial

"described as a Profit Sharing Trust, with the balance reported"

Abbott Laboratories Stock Retirement Trust financial

"Balance in the Abbott Laboratories Stock Retirement Trust as of"

Payment of exercise price or tax liability financial

"Payment of exercise price or tax liability by delivering or withholding"

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for these transactions"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transactions did ABBOTT LABORATORIES (ABT) report for John A. McCoy Jr.?

The filing reports a sale of 27 common shares on September 2, 2026 and a disposition of 52 shares on September 1, 2026 for payment of exercise price or tax liability, plus an indirect holding of 59 shares in a company retirement trust.

At what prices were the recent ABT insider share dispositions executed?

John A. McCoy Jr. reported selling 27 shares at $109.54 per share on September 2, 2026, and 52 shares at $110.36 per share on September 1, 2026, the latter for payment of exercise price or tax liability by delivering or withholding securities.

How many ABBOTT LABORATORIES (ABT) shares were used to pay exercise price or tax liability?

The filing states that 52 common shares of ABBOTT LABORATORIES were delivered or withheld on September 1, 2026 for payment of exercise price or tax liability at a reported price of $110.36 per share.

Does the ABT Form 4 show any indirect share holdings for John A. McCoy Jr.?

Yes. The Form 4 shows an indirect holding of 59 common shares in the Abbott Laboratories Stock Retirement Trust, described as a Profit Sharing Trust, with the balance reported as of September 1, 2026.

Were John A. McCoy Jr.’s ABT transactions made under a Rule 10b5-1 plan?

No. The Form 4 indicates no Rule 10b5-1 trading plan, as the document-level checkbox affirming such a plan is not checked for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 06:15 PM Accepted by SEC EDGAR 09/03/2026 - 06:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCCOY JOHN A. JR.

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VICE PRESIDENT AND CONTROLLER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares without par value	09/01/2026		F		52	D	$110.36	24,576	D
Common shares without par value	09/02/2026		S		27	D	$109.54	24,549	D
Common shares without par value								59(1)	I	Profit Sharing Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2026.

	/s/ John A. McCoy, Jr. by Jessica H. Paik, Attorney-in-Fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)